Aratana Therapeutics, Inc. Announces Termination of Offering of Common Stock
November 28 2017 - 06:56PM
PR Newswire (US)
LEAWOOD, Kan., Nov. 28, 2017 /PRNewswire/ -- Aratana
Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company
focused on licensing, developing and commercializing innovative
therapeutics for dogs and cats, today announced that it has
terminated the offering of shares of its common stock that was
announced on Monday, November 27,
2017. The company believes that current market conditions
are not conducive for an offering on terms that would be in the
best interests of its stockholders.
Contacts
For investor inquires:
Craig Tooman
ctooman@aratana.com
(913) 353-1026
For media inquiries:
Rachel Reiff
rreiff@aratana.com
(913) 353-1050
View original content with
multimedia:http://www.prnewswire.com/news-releases/aratana-therapeutics-inc-announces-termination-of-offering-of-common-stock-300563255.html
SOURCE Aratana Therapeutics, Inc.
Copyright 2017 PR Newswire
ARATANA THERAPEUTICS, INC. (NASDAQ:PETX)
Historical Stock Chart
From Feb 2024 to Mar 2024
ARATANA THERAPEUTICS, INC. (NASDAQ:PETX)
Historical Stock Chart
From Mar 2023 to Mar 2024